Inflammatory Disease Impact Factor

Journal of Inflammation aims to become leading online journal on inflammation and online journals replace printed ones over the next decade, the main open access inflammation journal. Open access guarantees a larger audience, and thus impact, than any restricted access equivalent, and increasingly so, as the escalating costs of printed journals puts them outside University budgets. The unrestricted access to research findings in inflammation aids of promoting dynamic and productive dialogue between industrial and academic members of inflammation research community, which plays such an important part in the development of future generations of anti-inflammatory therapies. Journal of Inflammation operates using a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. The benefit of single-blind peer review is traditional model of peer review that many reviewers are comfortable with, and it facilitates dispassionate critique of manuscript.